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Abstract
A key process in the lifecycle of the malaria parasite Plasmodium falciparum is the fast invasion of human erythrocytes. Entry
into the host cell requires the apical membrane antigen 1 (AMA-1), a type I transmembrane protein located in the
micronemes of the merozoite. Although AMA-1 is evolving into the leading blood-stage malaria vaccine candidate, its
precise role in invasion is still unclear. We investigate AMA-1 function using live video microscopy in the absence and
presence of an AMA-1 inhibitory peptide. This data reveals a crucial function of AMA-1 during the primary contact period
upstream of the entry process at around the time of moving junction formation. We generate a Plasmodium falciparum cell
line that expresses a functional GFP-tagged AMA-1. This allows the visualization of the dynamics of AMA-1 in live parasites.
We functionally validate the ectopically expressed AMA-1 by establishing a complementation assay based on strain-specific
inhibition. This method provides the basis for the functional analysis of essential genes that are refractory to any genetic
manipulation. Using the complementation assay, we show that the cytoplasmic domain of AMA-1 is not required for correct
trafficking and surface translocation but is essential for AMA-1 function. Although this function can be mimicked by the
highly conserved cytoplasmic domains of P. vivax and P. berghei, the exchange with the heterologous domain of the
microneme protein EBA-175 or the rhoptry protein Rh2b leads to a loss of function. We identify several residues in the
cytoplasmic tail that are essential for AMA-1 function. We validate this data using additional transgenic parasite lines
expressing AMA-1 mutants with TY1 epitopes. We show that the cytoplasmic domain of AMA-1 is phosphorylated.
Mutational analysis suggests an important role for the phosphorylation in the invasion process, which might translate into
novel therapeutic strategies.
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Introduction
Invasion of red blood cells (RBCs) is one of the critical points
in the erythrocytic life cycle of the malaria parasite Plasmodium
falciparum. The invasive form of the parasite, the merozoite,
harbours a set of specialized secretory organelles, in particular
two varieties called rhoptries and micronemes, which house key
proteins involved in the invasion process. Upon invasion, these
proteins are released either onto the surface of the invading
merozoite or into the intercellular matrix, where they mediate
host-cell recognition, receptor binding, active invasion and the
formation of the parasitophorous vacuole. Some of these
proteins, like the apical membrane antigen-1 (AMA-1,
PF11_0344), are primary targets for vaccine development since
antibodies directed against these proteins can prevent invasion
(reviewed in [1]). In P. falciparum, the full length AMA-1 protein
is a 83 kD type I transmembrane protein stored in the
micronemes [2,3]. Upon egress of the merozoite from an
infected erythrocyte, AMA-1 is translocated onto the merozoite
surface where it is concentrated at the apical pole [4]. This
translocation process is accompanied by N-terminal cleavage of
a prodomain, which results in a 66 kDa protein that is itself
further cleaved during invasion, releasing a 48 and a 44 kDa
isoform into the extracellular environment [5,6].
AMA-1 plays an essential role in the invasion process [7,8] and
is well conserved between apicomplexan parasites. However, its
biological function is still unknown. Several studies have
implicated Plasmodium AMA-1 function in erythrocyte binding
[9,10] and in reorientation of merozoites on the surface of RBCs
[11]. More insights were gained in the related apicomplexan
parasite Toxoplasma gondii, where it was shown that AMA-1 is
involved in the regulation of rhoptry secretion and in mediating
the formation of the moving junction, an area of intimate contact
between the invading parasite and the host cell membrane [12–
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in the extremely rapid invasion process remains a mystery.
There is significant polymorphism among ama-1 alleles in P.
falciparum field isolates [15,16]. This diversity represents a major
hurdle for the development of an AMA-1-based vaccine, as human
driven immune selection leads to diversification of ama-1 alleles
[16,17]. Significantly, it is known that invasion-inhibitory
antibodies against the AMA-1 type of one parasite strain have
no or significantly less efficacy against other parasite strains [17].
Residues responsible for this antigenic escape mechanism have
been mapped [18] and co-crystallization studies reveal a
hydrophobic cleft in the AMA-1 ectodomain as one of the binding
sites for inhibitory antibodies [19]. This functional inactivation of
AMA-1 can be mimicked by small peptides [20].
Detailed functional analysis of essential proteins like AMA-1 is
hampered in P. falciparum by the limited availability of reverse
genetic tools like RNAi or inducible gene knock-out systems [21].
Here we have generated a GFP-tagged full-length AMA-1 cell line
that allows visualization of the surface translocation and
assessment of the membrane mobility of this key protein in live
parasites. Furthermore, we have established a complementation
assay based on strain-specific inhibition to functionally character-
ize the crucial sequence determinants of AMA-1.
Results
Full-length AMA-1-GFP is correctly trafficked in
transgenic parasites and is recognized by isoform-
specific antibodies
It has been previously shown that AMA-1 is a microneme
protein that is processed and translocated onto the surface of
merozoites around the time of schizont rupture [6]. In order to
functionally analyze AMA-1, full length AMA-1-GFP chimeras
derived from either a 3D7 or W2mef background were episomally
expressed under the AMA-1 promoter [22] in 3D7 parasites
resulting in two parasite strains: AMA-13D7-GFP and AMA-1W2-
GFP (Figure 1A). Both chimeras are expressed and correctly
processed as shown by Western blot analysis (Figure 1B and 1C).
The expression and processing of endogenous AMA-1 is not
affected by the ectopic expression of the transgenes (Figure 1C).
The 3D7 specific, monoclonal antibody 1F9 exclusively recognizes
AMA-13D7-GFP but not AMA-1W2-GFP as shown in Figure 1D
[23]. In order to confirm correct localization of the AMA-1-GFP
fusion, we localized the protein in unfixed parasites (Figure 1E)
and colocalized AMA-1W2-GFP with the endogenous protein in
fixed parasites using the 3D7 specific monoclonal antibody
(Figure 1F). The distribution of AMA-1-GFP is identical to
endogenous AMA-1. The GFP-fusion protein is localized at the
apical end of forming merozoites (s) and is distributed onto the
surface in free merozoites (m). To visualize AMA-1 dynamics
during schizont rupture and merozoite release, video fluorescence
microscopy was undertaken using the AMA-1-GFP parasite lines
(Figure 1G and Video S1 and Figure S1). Strong apical GFP
fluorescence with some minor peripheral merozoite surface
staining was observed prior to schizont rupture (Figure 1G, left)
and immediately after merozoite release (Figure 1G, right). This
AMA-1-GFP distribution is indistinguishable from AMA-1 in wild
type parasites (Figure 1H) and in agreement with previously
published studies of AMA-1 localization [24–26]. Over time, the
initially apical AMA-1 becomes equally distributed over the
periphery in free merozoites as shown in Figure 1E and 1F. To
further analyze the mobility of peripheral AMA-1-GFP we used
fluorescence recovery after photobleaching (FRAP) analysis of
merozoites with predominantly peripheral GFP distribution
(Figure S2). The qualitative analysis of the FRAP data revealed
a high mobile fraction (89%+/24%) which shows that most
AMA-1 is not associated with an immobile entity and is freely
diffusing (Figure S2) as it was previously suggested [26].
Inhibition and complementation of endogenous AMA-1
using AMA-1-GFP–expressing parasites
To test the functional capacity of the episomally expressed
AMA-1-GFP fusion protein, the endogenous AMA-1 of 3D7
parasites was functionally inactivated using a strain specific
inhibitory peptide called R1 [20]. This peptide appears to bind
to a hydrophobic pocket within the AMA-1 ectodomain [20]. In
the presence of this peptide, invasion of 3D7 but not W2mef can
be completely inhibited (Figure 2A). Ectopic expression of AMA-
1W2-GFP in 3D7 parasites restored up to 50% of the invasion
capability compared to W2mef wild type parasites, while AMA-
13D7-GFP did not compensate the inhibitory effect of the peptide
(Figure 2A).
Live video microscopy reveals a role for AMA-1 after the
reorientation step
To reveal the consequences of functional inactivation of AMA-1
during invasion, parasites were observed by live video microscopy
(Figure 2B and 2C and Videos S2, S3, S4, S5, S6, and S7, and
Figures S3, S4, S5, and S6). As previously shown in P. knowlesi and
P. falciparum [27–29] merozoites attach, reorientate (Figure 2B,
black arrowheads) and subsequently invade the RBC (Figure 2B,
red arrowheads, and Videos S2 and S3 and Figure S3). The
primary attachment to the RBC surface is accompanied by
oscillatory deformation of the erythrocyte surface [11,27,29]
causing some extensive membrane- wrapping around the
merozoite. After this attachment phase, the merozoite reorientates
without apparent deformation of the RBC and invades the host
cell within seconds (Videos S2 and S3 and Figure S3). After
invasion, the infected erythrocyte goes through a reversible
echinocytosis (Video S4 and Figure S4). In the presence of the
R1 peptide, the invasion process by 3D7 or AMA-13D7-GFP
parasites appears to proceed normally through primary attach-
ment and reorientation, but then fails to progress further
Author Summary
Malaria is one of the most lethal parasitic diseases
worldwide, causing more than 1 million fatalities per
annum. Drug resistance is widespread, and a vaccine is not
available. One of the leading blood stage vaccine
candidates is the apical membrane antigen 1 (AMA-1),
which is well-conserved among apicomplexan parasites.
Although this protein plays an essential role in the invasion
of human red blood cells, little is known about the
molecular mechanisms underlying its function. In this
study we use live video microscopy in the presence and
absence of an invasion-inhibiting molecule to investigate
the function of AMA-1 in real time. We establish a
complementation assay based on strain-specific AMA-1
inhibition that allows functional characterization of this
protein on a molecular level. Using this approach, we
provide evidence that the intracellular cytoplasmic domain
of AMA-1 is directly involved in the invasion process and
that this domain is phosphorylated. We conclude that the
phosphorylation of AMA-1 might represent an attractive
target for novel therapeutic drug strategies independent
of the polymorphic extracellular domain.
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PLoS Pathogens | www.plospathogens.org 2 March 2009 | Volume 5 | Issue 3 | e1000322Figure 1. Expression and localization of 3D7- or W2mef-derived AMA-1 in transgenic parasites. (A) Schematic representation of
episomally expressed AMA-1 GFP fusion proteins. Signal peptide: blue; transmembrane domain: grey; pro-domain (P); domain I-III (DI-DIII) and
cytoplasmic domain (CPD): brown; GFP: green. 3D7-derived AMA-1 is represented in lighter brown colour. Cleavage sites of the signal peptide and
the pro-domain are marked with arrows. Sizes of the processed proteins are indicated either in green (GFP fusion) or in brown (endogenous protein).
(B) Western blot analysis of transgenic parasites using anti-GFP antibodies recognize 3D7- and W2mef-derived AMA-1-GFP proteins (the 110 kDa and
the processed 92 kDa AMA-1-GFP fusion protein) in the transgenic parasite lines but not in wild type (WT) parasites. (C) Western blot analysis of
transgenic AMA-13D7-GFP and AMA-1W2mef-GFP expression using an AMA-1 specific polyclonal antibody. In wild type parasites, AMA-1 is recognized
as an 83 kDa and a 66 kDa fragment (with and without pro peptide). In the transgenic cell lines, two additional proteins are apparent, representing
the 110 kDa and the processed 92 kDa AMA-1-GFP fusion. (D) The monoclonal 1F9 antibody recognizes only the 3D7-derived but not the W2mef-
derived AMA-1-GFP fusion protein. (E,F) Full-length AMA-1-GFP (green) localizes in schizonts (s) at the apical end of merozoites (m) and is distributed
over the surface of merozoites after schizont rupture. This is shown in both unfixed (E) and fixed parasites (F). The distribution of the endogenous
protein visualized with the 3D7-specific 1F9 antibody (red) is identical to the localization of the fusion protein (merge). (G,H) AMA-1-GFP dynamics
during schizont rupture. (G) Time lapse microscopy of live AMA1-GFP–expressing parasites before and after schizont rupture. Strong apical GFP
fluorescence with some surface staining was observed during schizont rupture and immediately after merozoite release (time frames from Video S1).
(H) This distribution is indistinguishable from AMA-1 in wild type parasites visualized by a polyclonal AMA1 antibody (green).
doi:10.1371/journal.ppat.1000322.g001
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although host cell entry is blocked at this stage, echinocytosis still
occurs (Video S7 and Figure S6), indicating that some decisive
interactions with the RBC plasma membrane are not prevented in
the presence of the R1 inhibitory peptide. This is further illustrated
by a sudden forward movement which appears to exert a
substantial force on the erythrocyte surface following reorientation
(Videos S5, S6, and S7).
Trafficking and translocation of AMA-1-GFP is
independent of the cytoplasmic domain
In order to analyze the involvement of the AMA-1 cytoplasmic
domain in microneme trafficking and subsequent surface translo-
cation, W2mef-derived AMA-1-GFP–expressing 3D7 parasites
lacking the cytoplasmic domain were generated (AMA-1Dtail-GFP,
Figure 3A). Expression of mutant AMA-1-GFP was verified in
immunoblots (Figure 3B). Fluorescence microscopy of unfixed
(Figure 3C) or fixed (Figure 3D) transgenic parasites reveals that
the deletion of the cytoplasmic domain does not affect AMA-1Dtail-
GFP localization. A putative interaction (and therefore assisted
trafficking) with the endogenous AMA-1 was excluded by using
immunoprecipitation and subsequent Western blot analysis
(Figure 3E). AMA-1-GFP and AMA-1Dtail-GFP (data not shown)
were immunoprecipitated using anti-GFP beads. Although anti-
AMA-1 antibodies showed successful co-immunoprecipitation of
AMA-1-GFP and the AMA-1 binding partner RON4 [12], no
endogenous AMA-1 could be detected. This argues against a
piggy-back trafficking of the deletion mutant with the endogenous
AMA-1.
The AMA-1 cytoplasmic domain is essential for its
function
The complementation assay provided the basis for analyzing the
phenotypic effects of various deletions and mutations introduced
into the AMA-1 protein and as such to functionally characterize
different parts of the AMA-1 molecule. First, we analyzed the
Figure 2. Inhibition and complementation of endogenous AMA-1 during invasion. (A) Invasion inhibition assays were performed in the
presence of 100 mg/ml R1 peptide. The figure shows the percentage of invasion (relative invasion) compared to invasion in the absence of the
inhibitory peptide. Error bars correspond to the standard deviation. All experiments were performed in triplicate in two independent experiments. In
contrast to W2mef wild type parasites, 3D7 parasites cannot invade erythrocytes in the presence of R1 peptide. While over-expression of 3D7-derived
AMA-1-GFP (AMA-13D7-GFP) cannot restore the invasion capability of 3D7 parasites, the expression of W2mef-derived AMA-1 (AMA-1W2mef-GFP) in
3D7 parasites does. (B,C) Time lapse of video microscopy showing erythrocyte invasion in the absence or presence of R1 peptide. (B) A merozoite
(arrowhead) attaches to the RBC, slowly reorients, and finally invades the erythrocyte. Reorientation is completed within 8 seconds, and the active
invasion (red arrowheads) is completed after 12–16 seconds. Frame rate is 1 second, increment 1. (C) Time lapse of merozoites trying to invade a RBC
in the presence of 100 mg/ml R1 peptide. Although AMA1 is functionally inactivated, the merozoite reorients (black arrowhead), and a forward
movement can be observed but no invasion occurs (red arrowhead). Timeframe 1 s, increment 1.
doi:10.1371/journal.ppat.1000322.g002
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R1 peptide, W2mef-derived AMA-1Dtail-GFP could not rescue the
invasion capability, unlike the full-length W2mef AMA-1-GFP
(Figure 4E). Thus, although trafficking of AMA-1 does not require
the cytoplasmic domain, invasion inhibition by R1 clearly
demonstrates that the cytoplasmic domain (AMA-1Dtail-GFP) plays
an essential role in the invasion process. To further dissect the role
of the cytoplasmic domain we introduced multiple alterations into
this domain and analyzed their functional consequences.
Functional conservation within the cytoplasmic domain
of AMA-1
In order to analyze the functional sequence requirements within
the cytoplasmic domain of P. falciparum AMA-1, we swapped
domains either with i) the homologous domain of P. vivax or P.
berghei or ii) the non-homologous domains of two well character-
ized type-I transmembrane proteins, that are implicated in
erythrocyte invasion and possess an equally short cytoplasmic
domain (EBA-175 and Rh2b, Figure 4A–4C). All chimeric
proteins were correctly expressed as GFP fusion proteins
(Figure 4D), colocalized with endogenous AMA-1 (data not
shown) and were proteolytically cleaved like the endogenous
protein (Figure 4D). Although AMA-1vivax and AMA-1berghei could
readily complement the endogenous protein, the cytoplasmic
domains of EBA-175 and Rh2b failed to do so (AMA-1EBA-175 and
AMA-1Rh2b, Figure 4E). This points towards distinctive features
within the AMA-1 cytoplasmic domain that seem to be required
for its function. This notion is further supported by a high degree
of conservation of this domain not only within the genus
Plasmodium but also with other apicomplexan parasites
(Figure 4B). Therefore, we tested which region of the cytoplasmic
domain is important for AMA-1 function. Deletions of the
proximal (AMA-1D571–588 and AMA-1D589–611) and C-terminal
(AMA-1D11 and AMA-1D5) portions of the cytoplasmic domain
functionally inactivated AMA-1. Furthermore, mutations of the
highly conserved residues DE594 (AMA-1DE-AA), DPE599 (AMA-
1DPE-AA), FW603 (AMA-1FW-AA) all resulted in functional inacti-
vation of AMA-1 with some residual function in the AMA-1DE-AA
Figure 3. Expression and localization of mutant AMA-1-GFP. (A) Schematic representation of episomally expressed mutant AMA-1-GFP fusion
proteins without cytoplasmic domain (AMA-1Dtail-GFP). (B) Expression of mutant AMA-1-GFP was verified using anti-GFP specific antibodies. (C,D) The
deletion of the cytoplasmic domain does not affect the localization of the AMA-1Dtail-GFP fusion protein. This is shown in unfixed (C) and fixed (D)
parasites. Mutant protein (green) colocalizes with the endogenous protein (red) as shown in the merge pictures. (E) Immunoprecipitation and
immunoblot of AMA-1-GFP– interacting proteins. Coloured marker lines show the predicted size of the endogenous (brown), or the GFP-tagged
AMA-1 (green). Supernatant (SN) of extract of AMA-1-GFP–expressing segmented schizonts was used on an AMA-1-GFP column. Supernatant (SN),
flow through (FT), washing (W1-3), and the elution fraction (E) were separated on an SDS-PAGE gel and probed with polyclonal anti-PfAMA1 (PR) and
anti-RON4.
doi:10.1371/journal.ppat.1000322.g003
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YD577 (AMA-1YD-AA), a residue lying within the N-terminal part
of the domain.
To further validate these findings and to improve the invasion
capability of parasite lines ectopically expressing AMA-1, the C-
terminal GFP tag was exchanged with a small TY1 epitope of 10
amino acids [30] in wild type AMA-1 (AMA-1W2-TY1) and in
those AMA-1 mutations that led to its inactivation (Figure 5A
and 5B). The substitution of GFP with the TY1 tag increased the
efficiency of the functional complementation by approximately
two fold (Figure 5C) and led to an invasion capability of the
AMA-1W2-TY1 parasite line that was comparable with that of
W2mef wild type parasites (Figure 5C). The lack of invasion
capability was not significantly changed in parasite lines
substituted with non-homologous cytoplasmic domains (AMA-
1EBA-175-TY1 and AMA-1Rh2b-TY1), or mutations within the
extreme C-terminus (AMA-1D5-TY1, AMA-1FW-AA-TY1 and
AMA-1PM-TY1). Evaluation of the TY1-tagged parasite lines
AMA-1DE-AA and AMA-1DPE-AA revealed an increased invasion
capacity, which however did not reach that of wild type AMA-
1W2-TY1. The lower invasion efficiency with the GFP tag might
be due to sterical hindrances compared to the much smaller TY1
tag.
The cytoplasmic domain is phosphorylated
During the invasion process AMA-1 is shed by a protease from
the merozoite surface releasing the extracellular domain into the
supernatant (Figure 6A). The remaining small C-terminus of
AMA-1 is carried into the host cell [24] (Figure 6B). A
bioinformatics screen predicted six amino acids within the
cytoplasmic domain to be phosphorylated (www.cbs.dtu.dk/
services/NetPhos) (Figure 4B). To validate phosphorylation, all
conserved putative phosphorylation sites (and those that might be
phosphorylated due to the substitutions) were mutated to generate
the parasite line AMA-1PM-GFP (Figure 4A). Taking advantage of
the increased length of the processed C-terminal fragment due to
the GFP tag, the released C-terminal fragments were easily
detectable as 45 and 49 kDa fragments (Figure 6A and 6C). The
introduced mutations (calculated to alter the MW by 0.6 kDa) led
to a clearly reduced molecular weight (significantly more than
0.6 kDa) of both the 45 and the 49 kDa fragments (Figure 6C). In
order to test if the observed shift in mobility was due to
phosphorylation, AMA-1-GFP was treated with lambda-phospha-
tase (Figure 6D). This reduced the apparent molecular weight of
wild type AMA-1-GFP, resulting in a size identical to that of the
phosphorylation mutant AMA-1PM-GFP, whereas AMA-1PM-
GFP itself showed no shift after the phosphatase treatment
(Figure 6E). Thus the observed size difference between the
mutated and wild type cytoplasmic domains of AMA1 is due to
phosphorylation. Interestingly, this phosphorylation mutant
(AMA-1PM) led to a functional inactivation of AMA-1 as shown
in the complementation assays (Figures 4E and 5C).
Discussion
The invasion of erythrocytes by malaria parasites is a well
orchestrated and fast process relying on precise signaling and
multiple protein-protein interactions [31]. Invasion can be
resolved into a series of distinct steps: i) an initial attachment of
the parasite and the host cell surface, which leads to a close
interaction between the membranes of the two cells and often
causes extensive deformation of the host cell, ii) reorientation of
the merozoite, bringing about intimate contact between the apical
end of the parasite and its host cell and iii) active penetration
[27,32,33]. While some proteins involved in these steps have been
characterized [31], the function of the leading blood stage vaccine
candidate AMA-1 in this process remains elusive. Here we report
on the detailed analysis of AMA-1 during invasion.
The expression of GFP-tagged full-length AMA-1 in transgenic
parasites allowed us for the first time to visualize and analyze the
distribution and function of AMA-1 during erythrocyte invasion.
In agreement with previous publications [24–26], differentially
distributed AMA-1 pools could be visualized: a major apically
restricted population and a minor peripherally located fraction
after merozoite egress. Does this imply dual function? On the one
hand these different properties could argue for the involvement of
peripheral AMA-1 in the reorientation process by its interaction
with erythrocyte receptors [10,11]. This could be achieved, for
instance, by an AMA-1 density gradient with highest concentra-
tions at the apical end. Apical AMA-1 could play an essential role
in the intimate contact between the apical pole and host cell that
culminates in the formation of a moving junction, a membrane
contact that migrates down the length of the invading parasite. On
the other hand, peripherally distributed AMA-1 could simply be
functionally redundant excessive AMA-1, while only apical AMA-
1 is required for invasion. Such a scenario was proposed for T.
gondii, where it was shown that TgAMA-1 is associated with two
proteins, RON2 and RON4, that colocalize with the moving
junction [13]. Furthermore, the conditional knock-out of Tgama-1
that resulted in its depletion impaired the ability of the parasite to
attach intimately to its host cell [14]. These two observations argue
against an essential role of AMA-1 in the steps preceding the
formation of the moving junction, at least in T. gondii. Video
microscopy in the presence of the invasion inhibitory peptide R1
was used to further examine AMA-1 function. To date only very
few video recordings of the actual erythrocyte invasion process
have been published [27–29] and none of these were made in the
presence of invasion inhibiting molecules. The results obtained by
comparing invasion in the presence and absence of R1 peptide
suggest a role for the hydrophobic cleft just prior to invasion, after
binding and reorientation (Figure 2 and Videos S3 and S5).
Interestingly, the essential reorientation seems to be independent
of erythrocyte deformation, strengthening the hypothesis of
merozoite reorientation by either active reorientation with the
use of motor proteins or a gradient of adhesive surface proteins
with higher affinity or avidity towards the apical pole of the
Figure 4. Functional analysis of the cytoplasmic domain of AMA-1. (A) Schematic representations of the mutations introduced into the
cytoplasmic domain of W2mef-derived AMA-1. (B) Alignment of the cytoplasmic domain of various AMA-1 homologues. The conservation is scored
and colour-coded by PRALINE (www.ibi.vu.nl). The scoring scheme works from 0 (for the least-conserved alignment position) up to 10 (for the most
conserved position). Amino acids predicted by NetPhos (www.cbs.dtu.dk/services/NetPhos) to be phosphorylated in the plasmodial protein are
scaled up according to their relative predicted probabilities. (C) Alignment of the cytoplasmic domain of AMA-1 with the cytoplasmic domain of EBA-
175 and Rh2b. (D) Expression of the cytoplasmic domain mutants was verified by Western blot analysis using anti-GFP antibodies. (E) Invasion
inhibition assays with all cytoplasmic domain mutants were performed in the presence of 100 mg/ml R1 peptide. Error bars correspond to standard
deviation. All experiments were performed in triplicate in two independent experiments. The parasite line AMA-1W2mef-GFP served as a positive
control. Except for the mutation of a conserved tyrosine (YD), all introduced mutations lead to a complete functional inactivation (in the case of the
mutant DE, to a drastically reduced function) of AMA-1-GFP.
doi:10.1371/journal.ppat.1000322.g004
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indicates triggering of motor proteins even though invasion is
inhibited. The apparent reorientation of the merozoite in the
presence of the R1 peptide was surprising given that AMA-1 was
shown to play an essential role in this process. This was previously
shown by using inhibitory, monoclonal antibodies directed against
P. knowlesi AMA-1 in combination with electron microscopy
analysis [11]. One simple explanation for this differing observation
could be that the P. knowlesi epitope recognized by inhibitory
antibodies and the hydrophobic pocket in P. falciparum AMA-1
recognized by the R1 peptide are distinct functional domains of
the AMA-1 ectodomain. This, once again, points to multiple
functions of AMA-1 during the invasion process. Alternatively, the
inhibition of the reorientation step by antibodies might be
primarily mediated by a sterical hindrance due to the size of the
antibodies and therefore might not reflect a functional property of
the AMA-1 molecule.
The observed induction of echinocytosis in the presence of R1
peptide could argue for the initiation of a moving junction.
Alternatively, transient echinocytes might be a consequence of
Figure 5. Expression and functional analysis of AMA-1-TY in transgenic parasites. (A) Schematic representations of the ectopically
expressed TY1-tagged AMA-1 with various mutations in the cytoplasmic domain (lighter brown and marked with an asterisk). (B) Expression of
W2mef-derived AMA-1-TY1 detected by Western blot analysis using an anti-TY1 antibody. Whereas no protein can be detected in wild type parasites,
a double band corresponding to AMA-183-TY1 and processed AMA-166-TY1 can be detected in AMA-1-TY1–expressing parasites. (C) Invasion
inhibition assays using AMA-1-TY1–expressing parasite strains. Assays were performed in the presence of 100 mg/ml R1 peptide and were performed
in triplicate on three independent occasions.
doi:10.1371/journal.ppat.1000322.g005
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cell during the invasion attempt, as reported for T. gondii [34].
Therefore, blocking of the hydrophobic pocket in the ectodomain
of AMA-1 could either induce a blockage of the formation of the
moving junction or the progression of the latter. One conceivable
explanation for this observation is that R1 binding directly affects
the interaction of AMA-1 with PfRON4 [12] or other unknown
proteins involved in the moving junction complex. Alternatively,
binding could interfere with conformational changes that might be
necessary for AMA-1 function, potentially disrupting the essential
role of the cytoplasmic domain. Functional knowledge about the
cytoplasmic domains of invasion-related type I transmembrane
proteins like AMA-1 is limited. Here we report that the
cytoplasmic domain does not play a role in trafficking or
translocation of the protein to the micronemes and subsequently
to the surface, but is essential for function. This intriguing finding
is reminiscent of previous work showing that although the
cytoplasmic domain confers a function in the members of the
EBL superfamily, these proteins are trafficked independently of
their cytoplasmic domain [22,35]. This is further supported by the
fact that cytoplasmic domain-swaps with either EBA-175 or Rh2b
do not interfere with trafficking but cannot complement AMA-1
function, pointing to a decisive role of this AMA-1 domain in the
invasion process. This function can be mimicked by the
homologous regions of the AMA-1 protein of P. berghei and P.
vivax that show a high degree of conservation (above 70% identity
within the cytoplasmic domains). In the cytoplasmic domain the
degree of conservation increases towards the extreme C-terminus.
Coincidentally, only mutations of residues positioned towards the
transmembrane domain such as YD577 show no effect on AMA-1
function.
We show that the cytoplasmic domain of AMA-1 is phosphor-
ylated and mutation of all putative phosphorylation residues
inactivates AMA-1 function. Furthermore, the phosphorylation
mutant, which possesses a fully functional AMA-1 ectodomain is
blocked just prior to invasion, suggesting a coordinated function of
the hydrophobic cleft and phosphorylation. In this context it is
interesting to note that AMA-1 appears not to be phosphorylated
Figure 6. Phosphorylation of the cytoplasmic domain. (A) After invasion, secondary processing of AMA-1-GFP N- and C-terminal of domain III
results in two additional AMA-1 GFP fragments of 44 and 49 kDa. Both fragments are indicated by coloured asterisks (49 kDa blue; 44 kDa red). (B)
Live images showing AMA-1-GFP distribution (green) in two young ring stage or reinvaded merozoites. Blue: DAPI-stained nucleus. (C) Western blot
analysis of AMA-1-GFP wild type and AMA-1-PM. Mutation of all putative phosphorylation sites to alanine within the cytoplasmic domain (PM,
reducing the calculated MW by 0.6 kDa) leads to a reduced molecular weight of approximately 3 kDa of both fragments. (D) Western blot analysis of
phosphatase-treated AMA-1-GFP. AMA-1-GFP was extracted and either treated with (+) or without (2) lambda-phosphatase followed by precipitation
and then subjected to Western analysis. The pellet fraction (P) and the precipitated lysate supernatant (SN) without any treatment was loaded as a
control. Treatment with lambda-phosphatase leads to a reduced molecular weight of approximately 3 kDa of both fragments, which is not seen in
the control (2). (E) The treatment of the phosphorylation mutant (PM) with phosphatase does not affect the mobility of AMA-1-PM (with (+) and
without (2) phosphatase treatment). Supernatant and pellet fraction served as controls. The size of all fragments is identical to that of the
phosphatase-treated wild type AMA-1-GFP.
doi:10.1371/journal.ppat.1000322.g006
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peptide mass fingerprinting did not recover any phosphorylated
AMA-1 in schizont material [5] (AMA-166 fragment). It will be
highly interesting to pinpoint the precise timing of AMA-1
phophorylation. This might help to unravel downstream effects
triggered through AMA-1. Eight kinases are co-transcriptionally
up-regulated together with AMA-1 [36]. Recently, Ono and co-
workers [37] showed that the secretion of apical organelles is
induced by the increase of the cAMP concentration in sporozoites
of P. falciparum and other Plasmodium species. The major
downstream effector of cAMP is protein kinase A (PKA), a serine
threonine kinase l. Further, four of the up-regulated kinases display
features of Ca
2+-dependent kinases in P. falciparum. The depen-
dence of efficient secretory organelle release on a raised
concentration of intracellular Ca
2+ is well established in T. gondii
[38,39], Cryptosporidium parvum [40] and was also suggested for
Plasmodium [31]. Given that the cAMP and Ca
2+ signaling
pathways are intertwined in the parasite [41], the cytoplasmic
domain of AMA-1 might function as a sensing device triggering
downstream events like rhoptry secretion. It is noteworthy that the
conditional AMA-1 knockout in Toxoplasma leads to defective
rhoptry secretion [14]. Phosphorylation of the cytoplasmic domain
might induce a conformational change in the extracellular domain
resulting in its functional activation. Although phosphorylation
seems to be a prerequisite for AMA-1 function, mutagenesis of
conserved amino acids that are not predicted to be phosphorylated
also interfered with AMA-1 function. These residues might be
crucial for the interaction with downstream proteins that are
involved in the invasion process. Alternatively, phosphorylation
might depend on the recognition of surrounding non-phosphor-
ylated residues. To further understand the functional effect of
phosphorylation, it will be important to pinpoint the phosphor-
ylation sites, the phosphorylating kinase(s), the downstream
effector proteins, the precise moment of phosphorylation and
then correlate this with individual invasion steps.
In summary, our findings provide evidence that AMA-1 is not
only an essential part in the moving junction but also that
phosphorylation of the cytoplasmic domain might be a prerequi-
site for invasion. This might translate into important novel
therapeutic strategies using AMA-1-phosphorylating kinases as
drug targets to inactivate this crucial player of erythrocyte invasion
circumventing any antigenic escape mechanisms of the parasite.
Materials and Methods
Parasites strains and transfection
Plasmodium falciparum asexual stages were cultured in human 0
+
erythrocytes according to standard procedures [42]. W2mef is
derived from the Indochina III/CDC strain. 3D7 parasites were
transfected as described previously [43] with 100 mg of purified
plasmid DNA (Invitrogen). Positive selection for transfectants was
achieved using 10 nM WR99210, an antifolate that selects for the
presence of the human dhfr gene.
Nucleic Acids and DNA constructs
ama-1 was either amplified from 3D7 or W2mef P. falciparum
cDNA (s. Tab. 1). Additionally, cDNA from P. vivax and P. berghei
was used. In vitro mutagenesis of ama1 was achieved by using a two-
step primer directed PCR mutagenesis method [44] (Table S1)
with proof reading Vent polymerase (NEB). To ensure correct
timing of transcription, expression of the AMA-1 transgenes was
controlled by the AMA-1 promotor using the pARL-AMA1-GFP
Vector [22]. Constructs were cloned into the KpnI and AvrII
restriction sites of the transfection vector and sequences were
confirmed by sequencing.
Antisera and immunoblots
Antibodies used in immunodetection were rabbit polyclonal anti
AMA-1 [26] anti AMA-1 monoclonal 1F9 [23], monoclonal anti
TY1 (Diagenode) and monoclonal anti-GFP (Roche). Anti-AMA-1
was diluted 1:500, anti TY1 was used 1:1500, 1F9 and anti-GFP
antibodies were diluted 1:1000 in phosphate-buffered saline (PBS)
with 3% w/v skim milk. Immunoblots were performed using
standard procedures and developed by chemiluminescence using
ECL (Amersham International). Secondary antibodies were sheep
anti-rabbit IgG horseradish peroxidase (Sigma) and sheep anti
mouse IgG horseradish peroxidase (Roche) used 1:5000.
Immunofluorescence assays
Immunofluorescence assays (IFAs) were performed on fixed
parasites as previously described [35,45]. Fixed parasites were
incubated for 1 h with primary antibodies in the following
dilutions: rabbit anti-AMA-1 (1:1000), mAB 1F9 (1:2000).
Subsequently, cells were incubated 1:2000 with Alexa-Fluor 594
goat anti-rabbit IgG or Alexa-Fluor 488 goat anti-mouse IgG
antibodies (Molecular Probes) and with DAPI at 1 mg/ml (Roche).
Images of GFP-expressing parasites and immunofluorescence
assays were observed and captured using a Zeiss Axioskop 2plus
microscope, a Hamamatsu Digital camera (Model C4742-95) and
OpenLab software version 4.0.4 (Improvision Inc.).
Confocal and video microscopy
Confocal pictures were generated using a Fluoview 1000
(Olympus) or a SP5 (Leica) confocal microscope. Images were
analyzed and processed using either Photoshop or ImageJ software
(rsb.info.nih.gov/ij/). Parasites were taken from blood-culture,
kept at 37uC and imaged immediately after withdrawal.
Video microscopy was performed using an Axiovert 200 M
‘‘Cell observer’’ with a temperature and CO2 controlled incubator
at 37uC and 5% CO2. Briefly, parasites from culture where diluted
1:100 in pre-warmed complete Media (Gibco) and 5% Albumax,
(Sigma) without phenol red. 100 ml of this suspension was imaged
either with, or without 100 mg/ml R1 inhibiting peptide in 35 mm
glass bottom culture dishes (MatTek, Ashland, MA, USA). Image
acquisition was performed with an AxioCam HRm camera (Zeiss)
and Axiovision (Zeiss).
Immunoprecipitation
AMA-1-GFP was immunoprecipitated using conjugated anti-
GFP antibody agarose beads (MBL). Briefly, synchronized late
parasite cultures were collected and saponin lysed. The parasite
pellet was incubated with lysis-buffer (50 mM Tris-HCL pH 7,2,
250 mM NaCl, 0,1% NP-40, 2 mM EDTA, 10% Glycerol)
containing complete protease inhibitor without EDTA (Roche) for
3 h at 4uC. After centrifugation for 30 min at 16.000 g the
supernatant was incubated with anti-GFP agarose beads for 1 h at
4uC. Beads were washed three times with lysis buffer. Bound
proteins were eluted with non-reducing SDS sample buffer and
cooked for 5 min. Supernatant, flow through, wash and elution
fractions were subjected to Western blot analysis. The Blot was
probed using either polyclonal anti-AMA-1-PR or monoclonal
anti-RON4 antibodies.
Erythrocyte invasion assays
Parasite erythrocyte invasion assays were performed using 3D7
and transgenic parasites expressing various AMA-1 mutants in the
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Dickinson FACSaria fluorescence activated cell sorter (FACS).
Sorbitol synchronized parasite culture [46] (4% hematocrit, 0,5-
1% parasitemia, late trophozoites) was incubated in a 96-well Plate
(100 ml per well) under standard culturing conditions for 48 hours
to allow reinfection in the presence or absence (control) of 100 mg/
ml R1 [20]. After reinvasion occurred, parasites where stained
with 1 mg/ml ethidium bromide for 30 minutes at 37uC, washed
three times with media and then counted using the FACS. Assays
were performed in triplicates on three independent occasions.
Phosphatase assays
Sorbitol synchronized parasites were harvested after reinfection
of erythrocytes. Parasites were released from host cells by saponin-
lysis. The parasite pellet was resolved in 10 volumes of ice cold lysis
buffer (50 mM Tris-HCL pH 7,2, 250 mM NaCl, 0,1% NP-40,
10% Glycerol) containing complete protease inhibitor (Roche) w/
o EDTA and incubated for 180 minutes at 4uC. The lysate was
centrifuged at 16.000 g and aliquots of the supernatant were
subjected to lambda protein phosphatase (lPPase, NEB Biolabs)
treatment as stated in the manufacturer’s instructions. Briefly,
160 ml supernatant was incubated for 15 minutes with 400 U of
lPPase at 30uC. Subsequently, the mixture was precipitated with 4
volumes of ice-cold acetone (Sigma). Precipitated protein was
dissolved in non-reducing SDS sample buffer and analyzed on
SDS-Page and Western blot analysis using anti-GFP antibodies.
Supporting Information
Figure S1 Video S1 file depicted in time-lapse micrographs
Found at: doi:10.1371/journal.ppat.1000322.s001 (0.4 MB TIF)
Figure S2 FRAP analysis of surface exposed AMA-1-GFP in
free merozoites. (A) Representative pictures of a bleached
merozoite at different time points PB (pre bleach), B (bleach
pulse), post B (post bleach), and 2 s ABP (2 seconds after the
bleach pulse). The bleached area is indicated as white area. FRAP
data was collected in 13 independent experiments. (B) Kinetics of
the fluorescence for every single region of interest (ROI). Positions
of the ROIs are indicated in the inlay. The bleach impulse was at
0.6 seconds. All ROIs in the cell are affected by the bleach pulse.
In the bleached area, fast recovery can be observed (green). In the
apical ROI (violet) the loss of fluorescence is delayed by
0.2 seconds. 50% of surface fluorescence (violet) is lost within
0.157 seconds. Background fluorescence was measured in the
rectangular ROI (orange). (C) Qualitative analysis: the FRAP
curve was normalized by pre-bleach fluorescence intensity. Time
point zero indicates the bleach impulse when recovery starts.
Fluorescence recovery halftime (t/2) in the bleached area was
0,148 s (+/20.04 s), and the mobile fraction was calculated to be
89% (+/24%). Method: For analysis of the mobility of AMA-1-
GFP on the merozoite surface, a small bleach area was chosen and
bleached with a single pulse using Olympus Fluoview 1000. Due to
the relatively small amount of GFP in a small area, the pinhole was
set to 2 Airy. The data was analyzed using the IgorPro script
K_FRAPcalcV9e.ipf by Kota Miura (http://www.embl.org/
cmci/downloads/frap_analysis.html) in the software IgorPro
(Wavemetrics) using the protocol proposed by Phair et al.
(2004). FRAP curves were normalized using the following formula:
Ifrap{norm t ðÞ ~
Iwhole{pre
Iwhole t ðÞ {Ibase t ðÞ
:Ifrap t ðÞ {Ibase t ðÞ
Ifrap{pre
ð1Þ
Ifrap(t) is the temporal change in the intensity at the frap-ROI,
Ibase(t) is the background intensity outside cells, Ifrap-pre is the
average intensity before the bleaching at the frap-ROI, Iwhole(t) is
the temporal changes in the intensity of the whole cell, Iwhole-pre
is the average intensity of the cell before the bleaching. Then the
normalized FRAP curve Ifrap-norm(t) was fitted with the following
equation:
It ðÞ ~y0zAe{t1t: ð2Þ
Mobile fraction was calculated by
Mob~
{A
1{ y0zA ðÞ
; ð3Þ
and the half-maximum intensity time was calculated by
t1=2~
ln 0:5
{t
: ð4Þ
Graphs where generated in Graphpad Prism5 or Igorpro.
Found at: doi:10.1371/journal.ppat.1000322.s002 (0.6 MB TIF)
Figure S3 Video S3 file depicted in time-lapse micrographs
Found at: doi:10.1371/journal.ppat.1000322.s003 (0.3 MB TIF)
Figure S4 Video S4 file depicted in time-lapse micrographs
Found at: doi:10.1371/journal.ppat.1000322.s004 (0.4 MB TIF)
Figure S5 Video S6 file depicted in time-lapse micrographs
Found at: doi:10.1371/journal.ppat.1000322.s005 (0.3 MB TIF)
Figure S6 Video S7 file depicted in time-lapse micrographs
Found at: doi:10.1371/journal.ppat.1000322.s006 (0.5 MB TIF)
Table S1 Primers used for this study. Restriction sites for cloning
are underlined.
Found at: doi:10.1371/journal.ppat.1000322.s007 (0.04 MB
DOC)
Video S1 AMA-1 distribution during merozoite egress. AMA-1-
GFP–expressing schizont shows GFP fluorescence concentrated in
the apical tip of merozoites, consistent with a localization in the
micronemes. Prior to schizont rupture, the merozoite movement
becomes agitated before getting explosively released. Immediately
after merozoite release, AMA-1-GFP is distributed predominantly
in the apical area, but some fluorescence can be detected in the
peripheral part of the merozoite. 1 frame per second, movie
length: 303 seconds.
Found at: doi:10.1371/journal.ppat.1000322.s008 (1.8 MB MOV)
Video S2 Invasion of a merozoite into erythrocytes. A schizont is
bursting, thereby releasing multiple merozoites into the culture
media. A single merozoite can be observed to re-infect a new
erythrocyte. 1 frame per second, movie length: 149 seconds.
Found at: doi:10.1371/journal.ppat.1000322.s009 (7.3 MB MOV)
Video S3 Section of Video S2. A section of Video S2 illustrates
the different steps in the invasion process. The merozoite re-
orientates on the surface without noticeable deformation of the
erythrocyte. The invasion is a smooth and continual process. 1
frame per second, movie length: 24 seconds.
Found at: doi:10.1371/journal.ppat.1000322.s010 (0.4 MB MOV)
Video S4 Deformation and subsequent restoration of the
erythrocyte during the invasion process. Merozoites attack an
uninfected erythrocyte. At least one merozoite invades the
erythrocyte after several contacts with accompanying re-orienta-
tion and deformation of the erythrocyte surface (10 s–44 s).
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induced that is recovered after another approximately 40 s. 1
frame per second, movie length: 294 seconds.
Found at: doi:10.1371/journal.ppat.1000322.s011 (14.4 MB
MOV)
Video S5 Erythrocyte invasion is blocked in the presence of the
R1 peptide. Initial binding and intimate contact with the
erythrocyte membrane is not impacted by the inactivation of
AMA-1 due to R1 peptide binding. 1 frame per second, movie
length: 101 seconds.
Found at: doi:10.1371/journal.ppat.1000322.s012 (3.5 MB MOV)
Video S6 A section of Video S5 illustrates the different steps in
the R1 blocked invasion process. Although the merozoite re-
orientates on the surface as shown in Video S2 (without R1
peptide), the apical attachment does not culminate in the invasion
of the erythrocyte. Noteworthy, after apical attachment and a
short time period with no apparent movement, the exertion of
strong force leads to local deformation of the erythrocyte
membrane wrapping around the merozoite.
Found at: doi:10.1371/journal.ppat.1000322.s013 (0.7 MB MOV)
Video S7 Induction of echinocyte morphology in the presence of
R1 peptide. Although the parasite is not able to proceed with the
invasion process after its re-orientation on the RBC surface, it is
able to induce very similar morphological changes observed in the
invasion process in the absence of R1 peptide.
Found at: doi:10.1371/journal.ppat.1000322.s014 (7.1 MB MOV)
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